John K. Dickson, PhD, is Head of Chemistry at Clear Creek Bio. John is a medicinal chemist with over 30 years of experience in pharmaceutical research from early discovery to clinical candidate development. He served as Group Leader at Bristol-Myers Squibb and has held various positions of increasing responsibility in the biotech sector. He is a co-inventor of lomitapide (Juxtapid), and holds 28 US patents. John obtained his BS in chemistry from the University of North Carolina Chapel Hill and his PhD in organic chemistry from Duke University.

585 Massachusetts Avenue
Cambridge, MA 02139
info@clearcreekbio.com